Related Experiment Video
Updated: Jan 31, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
Published on: January 22, 2011
Clinical utility of next-generation sequencing in precision oncology
Anna Hux1, Amanda Lewis, Drew Sachwitz
1At the time this article was written, Anna Hux, Amanda Lewis, and Drew Sachwitz were students in the PA program at Wake Forest School of Medicine in Winston-Salem, N.C. Ms. Hux now practices hematology/oncology at Vanderbilt University Medical Center in Nashville, Tenn. Ms. Lewis now practices in the ED at Chippenham Hospital in Richmond, Va. Mr. Sachwitz practices in the orthopedic department at Highland Hospital in Oakland, Calif. Tanya Gregory is an assistant professor and director of student services in the Department of PA Studies at Wake Forest. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
The Precision Medicine Initiative (PMI) aims to change the way diseases are diagnosed and treated by taking into account a patient's genome, lifestyle, and environment. This type of research also uncovers potential biomarkers that can lead to the development of novel targeted therapies. Next-generation sequencing (NGS) is a new technology that facilitates collection of this genetic information by processing large amounts of DNA in an efficient and cost-effective way. NGS is particularly useful in oncology and has already begun to transform cancer management.
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Uncertainty in Measurement: Accuracy and Precision
Accuracy and Precision
Cis-regulatory Sequences
The Precise Definition of a Limit
Sequences

